Latest From Our Articles

Larry Langdon
/ Categories: Lyme Disease

Is It Lyme Disease or Multiple Sclerosis (MS)?

Multiple Sclerosis

Lyme disease is caused by Borrelia burgdorferi, a bacterium known as a spirochete that is transmitted by the deer tick. The spirochete can be transmitted to humans or animals through the bite of a tick, with Lyme disease symptoms appearing in days or months. Sixty to eighty percent of Lyme disease patients get a big, crimson rash that looks like a bulls-eye. A flu-like illness with fever, headache, stiff neck, and muscle and joint discomfort are among the other symptoms.

Lyme disease can cause delayed neurologic symptoms such as weakness, blurred vision due to optic neuritis, dysesthesias (sensations of itching, burning, stabbing pain, or "pins and needles"), confusion and cognitive dysfunction, and fatigue, which are similar to those seen in multiple sclerosis (MS). Lyme disease symptoms can come and go in a relapsing-remitting pattern. Lyme disease can also cause additional abnormalities that are comparable to those found in MS, such as positive findings on magnetic resonance imaging (MRI) scans of the brain and cerebrospinal fluid analyses (CSF).

Because of the similarity in symptoms and test findings, some persons with MS have sought testing for Borrelia antibodies to evaluate if their neurologic problems are caused by Lyme disease or true MS. The distinction is essential because Lyme disease often responds to antibiotic medication, especially when treated early on, but MS does not.

Several Medical conditions can have similar symptoms. Feeling tired, dizzy or weak, experiencing numbness or tingling in the hands and feet or the onset of vision problems could be symptoms of MS or Lyme disease. Yet they are very different conditions with very different causes and treatments. An accurate diagnosis requires ruling out what is not going on.


What does Lyme Disease And Multiple Sclerosis Research Say?

The overlap between MS and Lyme disease diagnosis was investigated in two trials. The research was carried out in areas of Long Island, New York, where Lyme disease is endemic, or occurs often.

In the first trial, patients with Borrelia antibodies in their blood and a variety of "MS-like" neurologic symptoms were assessed using MRI, evoked potentials (EP), and CSF analysis, which included a test for Borrelia antibodies in the spinal fluid.

While individuals with MS-like symptoms had the most aberrant MRIs and were the only ones among those evaluated to have abnormal EP and oligoclonal bands in their spinal fluid (indicating an abnormal immune response), no Borrelia antibody was found in their spinal fluid.

The researchers came to the conclusion that the few patients who exhibited MS-like symptoms were most likely suffering from MS and had also been exposed to the Borrelia bacterium.

In a separate investigation, researchers examined for Borrelia antibodies in the blood of 100 persons who had been diagnosed with MS. Only one of the 89 persons who were diagnosed with MS had antibodies against Borrelia. Infection with Borrelia is uncommon in MS patients who live in an endemic location, the researcher stated. In the differential diagnosis of MS, Lyme disease is unlikely to play a substantial role. Furthermore, the existence of Borrelia antibodies does not establish that Borrelia is causing the neurological symptoms, merely that the organism has been infected previously.


Understanding Lyme Disease

Lyme disease is a bacterial infection spread by tick bites from infected black-legged or deer ticks. Ticks aren't naturally infected with the disease. They get it through eating an infected host animal. It is transmitted to people by ticks that adhere to the skin and transmit a spirochete bacteria called Borrelia burgdorferi through their bite. Tick populations are concentrated in certain locations of the country. Ticks are more common on the East and West coasts, as well as sections of the Midwest, though ticks can be found across the United States.


Understanding Multiple Sclerosis (MS)

MS is a neurological system disorder caused by an immune system that isn't working properly. When the immune system mistakenly attacks the myelin sheath, the protective coating protecting nerve fibres, MS affects the central nervous system (CNS). The transmission of information between the brain and the rest of the body is disrupted as a result. Numbness, muscle weakness, discomfort, tremors, balance and mobility issues, exhaustion, bladder problems, speech dysfunction, and other MS symptoms are caused by disruptions in nerve signals, which impact limb movement and sensations of sight and touch.


Why Is It So Difficult To Make An Accurate MS Diagnosis?

Because there is no single test for MS, getting an accurate diagnosis can be difficult. According to the findings of a new study published in the Journal Multiple Sclerosis and Related Disorders, roughly one in every five persons with various neurologic diseases is misdiagnosed as having MS. Because of the ambiguity, many people suffer from symptoms for months or even years before receiving an official MS diagnosis.

The initial symptoms of both can be similar:

Because the first symptoms of MS and Lyme disease can be identical, doctors employ a variety of procedures, including blood and imaging tests, to confirm a diagnosis.

Lyme disease is diagnosed through blood tests:

Your doctor will assess whether you live in, or have recently travelled to, a region known for the incidence of Lyme disease or the presence of deer ticks as part of the Lyme diagnosis routine. Blood testing are essential for detecting whether the bacterium that causes Lyme disease is present.

Blood tests seek for antibodies to Borrelia: the bacteria that causes Lyme disease, Borrelia burgdorferi, can infiltrate practically every organ or system in the body and produce Lyme disease.


Diagnosis of MS is By Elimination:

MS is typically diagnosed by a process of elimination.

Immunologic, environmental, viral, and genetic variables, on the other hand, may all have a role in the development of MS. Because no single approach - blood analysis, spinal tap, MRI, or other test - can definitively identify an MS diagnosis, the diagnosis is usually a process of elimination.


Lyme disease symptoms that overlap and differ from MS:

Lyme and MS share several similarities and have differences.

Lyme disease affects the neurological system in 10 to 15% of cases. In terms of neurologic symptoms and test results, Lyme and MS have a lot in common.

Lyme disease symptoms might begin within days following a tick bite or take months to show. Between 60 and 80 percent of persons with Lyme disease will develop a big, red rash that resembles a bulls-eye target which is one of the classic differentiating factors.

Flu-like symptoms such as lethargy, fever, headaches, swollen lymph nodes, and muscle and joint discomfort are also early markers. People may experience numbness and tingling as the condition worsens, and others may develop cognitive difficulties such as short-term memory loss and speech impairment. Lyme disease, unlike MS, can be successfully treated with medicines if detected early.

Lyme disease can cause delayed neurologic symptoms that are similar to those of multiple sclerosis. Muscle weakness, blurred vision, itching, burning, stabbing pain, or pins and needles, confusion, cognitive impairment, and weariness are some of the symptoms. Lyme disease, like MS, can present symptoms in relapsing-remitting stages, often known as remissions and exacerbations.

Other symptoms of Lyme disease include positive findings on MRI brain scans and cerebrospinal fluid (CSF) test results, however neurological issues tend to appear earlier in the disease's course. Lyme illness might look similar to multiple sclerosis, but there are some key differences. The most significant distinction is that Lyme disease is a bacterial illness, whereas MS is not, MS is an autoimmune condition.


The Treatment Objectives Of Lyme And MS Differ

MS treatment options vary and are aimed at managing symptoms and preventing relapse. Prescription medicines, corticosteroids, and plasma exchange are all used to help control the condition. Fatigue, depression, sexual and bladder difficulties, and other symptoms are treated with physical therapy, muscle relaxants, and other medications. Lyme disease may be treated and is usually cured, whereas MS is a chronic, generally progressive, lifelong condition that can range from moderate to severe.

Lyme Disease After Treatment: Post-treatment Lyme Disease (PTLD)

Lyme disease frequently responds to antibiotic medication, especially when treated early, but MS does not. Lyme disease treatment does not always result in complete recovery. Post-treatment Lyme Disease (PTLD) symptoms might be unclear and similar to those of other infections. The majority of people, on the other hand, recover and resume their normal lives.


Identifying what isn't working

Symptoms of medical diseases can be similar. Symptoms of MS or Lyme disease include fatigue, dizziness, and weakness, as well as numbness or tingling in the hands and feet and the development of vision issues. Nonetheless, these are two distinct illnesses with distinct causes and treatments. To make an accurate diagnosis, you must rule out everything that isn't working.


Diagnostic Blood Testing Might Be Perplexing

The Centers for Disease Control (CDC) recommends that blood tests be used to look for B. burgdorferi-specific antibodies, which are widely regarded as the most essential tool for diagnosing Lyme disease. Because it can take weeks for the body to build an immunological response that would result in positive test findings, the test may come back negative if the tick bite occurred less than a month ago. When a typical bulls-eye rash appears, but does not develop or is not present in all cases, it is easier to diagnose Lyme disease. 2,3 When neither MS nor Lyme can be definitively identified, the most typical course of action is to closely watch the patient over time to see whether there is any progression or differences in test results.

After early treatment for Lyme disease, the prognosis is usually quite excellent. When diagnosis and therapy are delayed, however, the prognosis worsens.

Antibiotics help most individuals with early Lyme disease recover and return to their usual state of health. Despite routine antibiotic therapy, some individuals experience chronic or recurrent symptoms due to Lyme disease. Lyme disease's persistent symptoms can have a significant detrimental impact on a person's health and quality of life. Patients commonly refer to this condition as chronic Lyme disease, despite the fact that a clinical case definition for chronic Lyme disease has proven difficult to come across.

Patients with Post Treatment Lyme Disease (PTLD) are those who are severely unwell 6 months or longer after receiving standard antibiotic therapy for Lyme disease. Severe fatigue, musculoskeletal discomfort, sleep disturbance, depression, and cognitive issues such as difficulty with short-term memory, are all signs of PTLD. Due to the lack of a direct diagnostic biomarker blood test, physicians have struggled to identify PTLD, and its presence has been disputed. Our clinical research, on the other hand, reveals that thorough patient evaluation combined with proper diagnostic tests can reliably identify individuals with a history of previously treated Lyme disease who exhibit the usual PTLD symptom patterns.


MS Prognosis

There's good news and bad news when it comes to the prognosis for multiple sclerosis (MS). MS is a chronic disorder with no cure, despite the fact that it isn't fatal.

Many persons with MS, however, face additional challenges that might reduce their quality of life. Despite the fact that the majority of people will never be seriously incapacitated, many may endure symptoms that cause pain, discomfort, and inconvenience.

MS-related complications, such as infections, cardiovascular illness, and accidents, can shorten a person's lifetime compared to someone who does not have MS. Treatment for these issues, on the other hand, can considerably lower the likelihood of a shorter lifespan.

The National Multiple Sclerosis Society (NMSS) reports that the average lifetime of people with MS has risen over time. However, the related difficulties shorten the average lifetime of people with MS by around 7 years compared to people who do not have MS.

Persons with MS die from many of the same diseases as people without the disease, such as cancer and heart disease. Aside from severe MS cases, which are uncommon, the prognosis for longevity is generally favourable.

The type of MS has an impact on the prognosis. Because each case is unique, there may be periods of inactivity.

MS generally has a greater impact on quality of life than it does on longevity. While certain kinds of MS may shorten life expectancy, they are the exception rather than the rule.

MS patients must deal with a slew of unpleasant symptoms that have a negative impact on their daily lives. They can be certain, however, that with proper treatment, their life expectancy will be similar to that of persons who do not have the disease.